好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

An analysis of fixed dose IV recombinant tissue plasminogen activator (rtPA) and clinical outcomes in acute ischemic stroke patients with body weight >100 kilograms: pooled data from three randomized clinical trials
Cerebrovascular Disease and Interventional Neurology
S8 - (-)
004
Authors/Disclosures
Shahram Majidi, MD (Icahn School of Medicine at Mount Sinai)
PRESENTER 		Dr. Majidi has nothing to disclose.
No disclosure on file
Kathleen Burger, DO (MedStar Georgetown University Hospital) Dr. Burger has nothing to disclose.
Hamza I. Maqsood, MD (Dept of Neurology) Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.